Fig. 4From: Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysisForest plot for all patients: early clinical response. DAL dalbavancin, DAP daptomycin, DEL delafloxacin, FUS fusidic acid, ICL iclaprim, LIN linezolid, OMA omadacycline, TED tedizolid, VA vancomycin + aztreonam, VAN vancomycin, VL vancomycin + linezolidBack to article page